文献速递心律失常心力衰竭与心肌病

磷酸受纳蛋白p.Arg14del突变携带者室性心律失常的个体化风险预测

Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers-reaching the frontiers of individual risk prediction.
PubMed 文献 · Eur Heart J · 2021-01-01

本研究基于679例无恶性室性心律失常史的PLN p.Arg14del突变携带者,中位随访4.3年,开发了针对恶性室性心律失常的突变特异性Cox预测模型。新模型区分能力优异(C-statistic 0.83,95%CI 0.78-0.88),优于现有PLN风险模型(C-statistic 0.68,95%CI 0.61-0.75)。

要点

  • 新模型纳入LVEF、24小时室早计数、负向T波数量和低电压心电图四个预测因子。
  • 新模型C-statistic为0.83,优于现有PLN风险模型的0.68。
  • 该模型有助于优化PLN p.Arg14del突变携带者一级预防ICD植入的风险分层。

核心结论

  • 针对PLN p.Arg14del突变携带者的新突变特异性室性心律失常预测模型优于现有PLN风险模型。
  • 利用突变特异性表型特征进行风险预测可提高准确性。

研究设计与样本

  • 研究纳入2009至2020年间基线无恶性室性心律失常史的PLN p.Arg14del突变携带者679例。
  • 采用Cox回归开发预测模型,并与现有PLN风险模型比较。

主要发现

  • 中位随访4.3年(IQR 1.7-7.4)期间,72例(10.6%)携带者发生恶性室性心律失常。
  • 显著预测因子包括左心室射血分数、24小时室性早搏计数、负向T波数量和低电压心电图。
  • 多变量模型C-statistic为0.83(95%CI 0.78-0.88)。
  • 现有PLN风险模型在全队列中C-statistic为0.68(95%CI 0.61-0.75)。

临床怎么用

  • 对于PLN p.Arg14del突变携带者,可采用包含LVEF、24小时室早计数、负向T波数量和低电压心电图的突变特异性模型进行个体化风险预测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: This study aims to improve risk stratification for primary prevention implantable cardioverter defibrillator (ICD) implantation by developing a new mutation-specific prediction model for malignant ventricular arrhythmia (VA) in phospholamban (PLN) p.Arg14del mutation carriers. The proposed model is compared to an existing PLN risk model. METHODS AND RESULTS: Data were collected from PLN p.Arg14del mutation carriers with no history of malignant VA at baseline, identified between 2009 and 2020. Malignant VA was defined as sustained VA, appropriate ICD intervention, or (aborted) sudden cardiac death. A prediction model was developed using Cox regression. The study cohort consisted of 679 PLN p.Arg14del mutation carriers, with a minority of index patients (17%) and male sex (43%), and a median age of 42 years [interquartile range (IQR) 27-55]. During a median follow-up of 4.3 years (IQR 1.7-7.4), 72 (10.6%) carriers experienced malignant VA. Significant predictors were left ventricular ejection fraction, premature ventricular contraction count/24 h, amount of negative T waves, and presence of low-voltage electrocardiogram. The multivariable model had an excellent discriminative ability {C-statistic 0.83 [95% confidence interval (CI) 0.78-0.88]}. Applying the existing PLN risk model to the complete cohort yielded a C-statistic of 0.68 (95% CI 0.61-0.75). CONCLUSION: This new mutation-specific prediction model for individual VA risk in PLN p.Arg14del mutation carriers is superior to the existing PLN risk model, suggesting that risk prediction using mutation-specific phenotypic features can improve accuracy compared to a more generic approach.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Verstraelen TE, van Lint FHM, Bosman LP, et al. Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers-reaching the frontiers of individual risk prediction. Eur Heart J. 2021. PMID: 34113975. doi:10.1093/eurheartj/ehab294

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。